Does baicalein attenuate hypertrophic scar formation via inhibition of the transforming growth factor-β/Smad2/3 signalling pathway?
Baicalein could serve as a promising agent for treatment of HPSs and a selective ALK5 inhibitor.
Infants in the ACT and Queanbeyan have a higher invasive pneumococcal disease incidence than similar populations worldwide. Better detection is the most likely explanation. This population would be ideal for studies of the 'real life' effectiveness of infant conjugate vaccination.